There has been some question about whether Medicare could legally pay for a vaccine that’s been authorized by the FDA on an emergency basis, as the first vaccines likely will be. Friday’s announcement with the major drugstore chains could potentially address those concerns for the slice of Medicare beneficiaries that reside in long-term care facilities.
While Trump has repeatedly promised a vaccine would be available by Election Day, no major pharmaceutical manufacturer plans to submit a vaccine to the FDA for review by Nov. 3. Pfizer CEO Albert Bourla announced Friday his company won’t have safety data necessary to submit its vaccine candidate until at least the end of November. Moderna, another frontrunner in the vaccine race, has also said it won’t be ready to file an application for emergency use authorization of its vaccine before the election.
What’s next: The FDA is scheduled to hold an advisory committee meeting on Oct. 22 to discuss the review process for a coronavirus vaccine once a company files for authorization or approval.